RPL35A is a key promotor involved in the development and progression of gastric cancer

Table 2 Relationship between RPL35A expression and tumor characteristics in patients with gastric cancer

Features	No. of patients	RPL35A expression		P value
Features	No. of patients	Low	High	P value
All patients	110	65	45
Age (years)				0.070
< 64	53	36	17
≥ 64	57	29	28
Gender				0.869
Male	84	50	34
Female	26	15	11
T Infiltrate				0.042
T1	5	4	1
T2	17	11	6
T3	65	41	24
T4	23	9	14
Lymphatic metastasis (N)				0.754
N0	20	13	7
N1	18	12	6
N2	26	12	14
N3	46	28	18
Stage				0.631
I	9	5	4
II	32	21	11
III	68	38	30
IV	1	1	0
Tumor size				0.591
< 5 cm	46	26	20
≥ 5 cm	55	34	21
Vessel carcinoma embolus				0.539
0	26	14	12
1	54	33	21
Nerve tumor infiltrates				0.425
0	36	22	14
1	20	10	10
Expession of Ki67				0.404
< 60%	47	25	22
≥ 60%	52	32	20
Expession of CD34				0.346
No	15	6	9
Yes	29	16	13
Expession of EGFR				0.531
No	85	47	38
Yes	14	9	5
Expession of VEGF				0.343
No	34	17	17
Yes	65	39	26
Expession of CDX2				0.892
No	18	10	8
Yes	82	47	35
Expession of Her2				0.948
No	72	41	31
Yes	26	15	11

ISSN: 1475-2867